Bronchiectasis management

Chronic structural changes in the bronchi that result in permanent dilation, impaired mucus clearance, and recurrent infections define bronchiectasis. The condition often develops following severe infections, immune deficiencies, or underlying disorders such as cystic fibrosis. Patients typically experience persistent cough, large volumes of sputum, recurrent chest infections, and progressive breathlessness. High-resolution CT scans remain the gold standard for diagnosis, providing detailed visualization of airway abnormalities and disease extent. Pulmonary function testing and microbiological cultures further guide treatment decisions.

Bronchiectasis management requires an integrated approach combining pharmacologic, physiotherapeutic, and lifestyle measures. Airway clearance techniques, including chest physiotherapy and mechanical devices, are central to improving mucus removal. Antibiotic therapy is tailored to culture results, often involving long-term or inhaled formulations to suppress chronic infections. Bronchodilators and anti-inflammatory medications help reduce airway obstruction and irritation. Vaccinations against influenza and pneumococcus protect against exacerbations, while pulmonary rehabilitation builds exercise capacity and resilience. Nutritional support is particularly important in individuals with coexisting conditions like cystic fibrosis. Regular follow-up ensures early detection of worsening lung function or new infections. By combining targeted medical care with self-management strategies, patients can achieve improved quality of life, fewer exacerbations, and slowed disease progression.